The facility was constructed with advanced computer-controlled manufacturing equipment, which provides increased manufacturing efficiencies and reduces production cost.
The new facility can produce up to 250 million tablets and 180 million capsules.
One of the most widely prescribed class of antimicrobials; cephalosporin is used in the treatment of bacterial infections with a broad spectrum of activity and safety profile.
Cephalosporin is a top selling class of drugs with a growth rate of 20% annually; China Pharma is actually planning to build a separate facility for the manufacture of the drug’s injectable form.
Read the full press release.
[In photo: nuclear cephalosporin, source: www.bmb.leeds.ac.uk]
Comment Preview